Stimulated glucose and insulin concentrations are frequently used to determine pharmacologic type 2 diabetes treatment outcomes [13], yet marked intra-individual variability in OGTT results across repeated tests is well-established [14]. Here, INS is linked to type 2 diabetes mellitus.